Skip to main content
INSP logo

INSP

Inspire Medical Systems, Inc.
$50.50 +1.35 (+2.75%) At close · Jul 15
Market Cap
$1.46B
Shares
28,813,153

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$50.50 Open$49.21 Day$48.80–51.43 52W$38.91–147.03 Avg vol 30d901K Short int4.7M · 16.3% float · 3.8d Short vol43% Last earningsMay 4, 2026 DataJan 2020–Jul 2026 Filing10-Q · May 4
Up next
Next earnings call
Aug 3, 2026 Est · unconfirmed · in 3 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed May 4, 2026
AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Equibles Rating blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Neutral Momentum Weak Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
      Market backdrop VIX 15.7 · calm Equity put/call 0.69
      Technical
      price trend
      Neutral
      50 / 200-day cross No cross
      Price vs 200-day avg −28%
      below
      Price vs 50-day avg +14%
      above
      RSI (14) 63
      neutral
      MACD trend Positive
      52-week position 11%
      near low
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Weak
      1-month return +23%
      trailing
      6-month return −48%
      trailing
      YTD return −45%
      this year
      Relative strength −58%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $44 › 200d $70 — 200d above 50d
      Institutional flow Accumulating
      24 of 303 funds reported for Jun 30 · net +17.4K sh shares · +7 new
      Insider flow Distributing
      Net -$175.9K over 90 days · 100% sells
      Short interest Rising
      16.29% of float · ▲ +30.8% MoM · 3.8 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr low
      303 holders — near 3-yr low, contrarian setup
      Squeeze score 78
      high risk · 0–100
      Fundamentals
      Excellent
      Revenue growth +62%
      Y/Y
      Gross margin 949%
      contracting
      EPS growth +179%
      Y/Y
      Free cash flow $78.5M
      Valuation P/E 11.5
      below peers
      Buyback $100.0M
      remaining
      Balance sheet $80.3M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 75%
      annualized · 1-yr
      Max drawdown −72%
      past year
      ATR 4.7%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record
      Latest guidance · from the 8-K filed May 4, 2026
      Revenue · Full Year 2026 Initiated $825M – $875M
      prior FY $911.98M midpoint −6.8% Y/Y
      Adjusted operating margin · Full Year 2026 Initiated 2% – 4%
      Diluted EPS · Full Year 2026 Initiated $0.07 – $0.62
      prior FY $4.89 midpoint −92.9% Y/Y
      Adjusted diluted EPS · Full Year 2026 Initiated $0.75 – $1.25
      Capital expenditures · Full Year 2026 Initiated $40M – $45M

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Neutral
      2 · 3 · 2
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −28% Bearish
      Price vs 50-day avg
      +14% Bullish
      RSI (14)
      63 Neutral
      MACD trend
      Positive Bullish
      52-week position
      11% Bearish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bearish · 2 of 6
      Trend (MA cross) No cross
      50d $44 › 200d $70 — 200d above 50d
      Institutional flow Accumulating
      24 of 303 funds reported for Jun 30 · net +17.4K sh shares · +7 new
      Insider flow Distributing
      Net -$175.9K over 90 days · 100% sells
      Short interest Rising
      16.29% of float · ▲ +30.8% MoM · 3.8 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr low
      303 holders — near 3-yr low, contrarian setup
      Price context
      position in its 52-week range
      52-wk low $39 Now $51 · 11% 52-wk high $147
      vs 200-day avg -28% vs 50-day avg +14%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Versus peers

      Medical Devices — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      INSP
      Inspire Medical Systems, Inc.
      this stock
      $1.46B -45.2% +62.2% 11.5 16.3%
      ABT
      Abbott Laboratories
      $154.67B -28.4% +5.7% 24.9 1.3%
      SYK
      Stryker Corp
      $120.24B -9.7% +11.2% 36.3 1.8%
      MDT
      Medtronic plc
      $102.89B -15.5% +8.4% 21.6 1.5%
      BSX
      Boston Scientific Corp
      $64.07B -54.9% +5.5% 18.0 1.9%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      303
      % held
      116.7%
      Reported
      24 of 303
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      277
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      4.7M
      Days to cover
      3.8d
      Change
      +1.1M sh
      View
      Short Volume
      Short vol %
      43%
      As of
      Jul 15, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      8.9K
      Value
      $408.4K
      As of
      Jun 29, 2026
      View
      Off-Exchange
      Off-exchange %
      84.4%
      Week of
      Jun 22, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$175.9K
      Buyers / Sellers
      0 / 2
      Buyers Sellers
      View
      Congressional Trades Sell
      Member
      Daniel Goldman
      Amount
      $1.0K–$15.0K
      Traded
      Apr 10, 2023
      View
      Financials
      Financials
      Revenue (FY)
      $912.0M
      Net income (FY)
      $145.4M
      EPS diluted
      $4.89
      View
      Buybacks
      Authorized
      $200.0M
      Remaining
      $100.0M
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Jun 26, 2026
      This year
      8
      View
      Proposed Sales
      Value
      $114.3K
      Shares
      2.6K
      Filed
      May 15, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      May 4, 2026
      View
      Investor Relations
      Latest news
      Correction: Inspire Medical Syste…
      Published
      Jul 6, 2026
      Upcoming events
      1
      View

      Performance

      5D 20D 120D MTD YTD
      INSP +2.4% +22.8% -47.5% +13.2% -45.3%
      SPY +1.3% -0.2% +10.1% +1.1% +10.7%
      vs SPY +1.2% +22.9% -57.6% +12.1% -55.9%

      Capital returns

      Buyback program · as of Mar 31, 2026
      Authorized
      $200.00M
      Spent (derived)
      $100.00M
      Remaining
      $100.00M
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1609550 CUSIP 457730109 13F (30d) 25 filings 20 filers Visit website Investor relations